Introduction
Materials and method
Study population
Data collection
Echocardiographic evaluation
Parameter | Cut-off values based on the European guidelines |
---|---|
1. Valve morphology | |
Annular dilatation | 3.5 cm |
2. Jet characteristics | – |
3. VC | 0.70 cm |
4. ERO | |
Organic MR | 0.40 cm2 |
Functional MR | 0.20 cm2 |
5. Regurgitant volume | |
Organic MR | 60 ml |
Functional MR | 30 ml |
MV inflow pattern | |
6. TVI MV/TVI LVOT ratio | 1.4 |
7. E-wave | 150 cm/s |
8. Systolic flow in pulmonary veins | Systolic reversal |
9. SPAP | 50 mmHg |
10. LAVI | 60 ml/m2 |
11. LV dimensions | |
Organic MR (LVESD) | 4.5 cma |
Functional MR (LVEDD) | 6.5 cm |
Statistical analysis
Results
Patient characteristics
Patient characteristics | |
Age, mean years ± SD | 80.4 ± 7.3 |
Male gender, n (%) | 94 (44.1) |
BSA, m2 ± SD | 1.9 ± 0.2 |
NYHA class ≥ III, n (%) | 105 (49.2) |
Pacemaker, n (%) | 14 (6.6) |
Rhythm, n (%) | |
Sinus rhythm | 176 (82.6) |
Atrial fibrillation | 37 (17.4) |
Comorbidities, n (%) | |
Hypertension | 121 (56.8) |
Diabetes | 67 (31.5) |
Coronary artery disease | 110 (51.6) |
Peripheral artery disease | 38 (17.8) |
Prior cerebrovascular accident | 40 (20.7) |
Pulmonary disease | 41 (19.2) |
Dialysis | 3 (1.4) |
Prior cardiac or thoracic intervention | 104 (48.8) |
Surgical characteristics | |
Logistic EuroSCORE, mean ± SD | 17.2 ± 9.3 |
Type of TAVR prosthesis, n (%) | |
Edward Sapien | 181 (85.0) |
Corevalve | 32 (15.0) |
Type of TAVR access, n (%) | |
Transfemoral, n (%) | 186 (87.3) |
Transapical, n (%) | 23 (10.8) |
Echocardiographic characteristics | |
ROSE-index score, median (IQR) | 0.0 (0.0–0.5) |
MR grade, n (%) | |
No (0) | 32 (15.0) |
Trace (0.5) or mild (1) | 135 (63.4) |
Moderate (2) | 30 (14.1) |
Moderate–severe (3) or severe (4) | 16 (7.5) |
MV etiology in case of MR, n (%) (n = 181) | |
Organic | 99 (54.7) |
Functional | 82 (45.3) |
Mitral stenosis ≥ moderate, n (%) | 10 (4.7) |
Aortic regurgitation ≥ moderate, n (%) | 34 (16.0) |
Tricuspid regurgitation ≥ moderate, n (%) | 22 (10.3) |
Aortic peak gradient, mean ± SD (n = 212) | 65.8 ± 21.1 |
Aortic mean gradient, mean ± SD (n = 211) | 39.1 ± 14.1 |
Other echocardiographic characteristics, mean ± SD | |
SPAP (mmHg) (n = 130) | 40.4 ± 15.0 |
LAVI (ml/m2) (n = 208) | 40.2 ± 14.6 |
Left ventricular EF (%) (n = 212) | 51.6 ± 12.6 |
Grading of MR related parameters
Parameter | % of patients scored per parameter | ||
---|---|---|---|
Pre-TAVR | Post-TAVR | P-value | |
1. Valve morphology | 97.7 | 94.8 | 0.109 |
2. Jet characteristics | 100.0 | 99.5 | 1.000 |
3. VCa | 94.8 | 94.8 | 1.000 |
4. EROa | 77.9 | 78.4 | 1.000 |
5. Regurgitant volumea | 65.7 | 67.6 | 0.603 |
MV inflow pattern | |||
6. TVI MV/TVI LVOT ratio | 81.2 | 77.0 | 0.314 |
7. E-wave | 66.2 | 62.0 | 0.336 |
8. SPAP | 62.0 | 49.3 |
0.005
|
9. Systolic regurgitant flow in pulmonary veins | 23.0 | 19.2 | 0.350 |
10. LAVI | 97.7 | 94.8 | 0.180 |
11. LV dimensions | 83.1 | 80.8 | 0.522 |
Echocardiographic results
Clinical characteristics | |
Early outcome | |
New permanent pacemaker, n (%) | 18 (8.5) |
Tamponade, n (%) | 4 (1.9) |
Myocardial infarction, n (%) | 0 (0) |
Cerebrovascular accident, n (%) | 6 (2.8) |
Late outcome (cumulative) | |
Post-TAVR, mean years ± SD | 1.0 ± 0.1 |
NYHA class ≥ III, n (%) | 15 (7.0) |
New permanent pacemaker, n (%) | 23 (10.8) |
Atrial fibrillation, n (%) | 45 (21.1) |
Re-hospitalization, n (%) | 57 (26.8) |
Aortic valve related | 0 (0) |
Due to CHF | 14 (6.6) |
Re-intervention, n (%) | 0 (0) |
Myocardial infarction, n (%) | 5 (2.3) |
Cerebrovascular accident, n (%) | 10 (4.7) |
Echocardiographic characteristics | |
ROSE-index score, median (IQR) | 0.0 (0.0–0.0) |
MR grade, n (%) | |
No (0) | 31 (14.6) |
Trace (0.5) or mild (1) | 149 (70.0) |
Moderate (2) | 16 (7.5) |
Moderate–severe (3) or severe (4) | 17 (8.0) |
Mitral stenosis ≥ moderate, n (%) | 10 (4.7) |
Aortic regurgitation ≥ moderate, n (%) | 21 (9.9) |
Tricuspid regurgitation ≥ moderate, n (%) | 26 (12.2) |
Aortic peak gradient, mean ± SD | 15.8 ± 6.7 |
Aortic mean gradient, mean ± SD | 8.2 ± 3.5 |
Other echocardiographic characteristics, mean ± SD | |
SPAP (mmHg) | 35.9 ± 10.6 |
LAVI (ml/m2) | 40.9 ± 16.8 |
Left ventricular EF (%) | 52.0 ± 11.1 |